Logo

Polyplus-transfection Raises $3.2M

Jan 11, 2011

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Polyplus-transfection said today that it has raised €2.5 million ($3.2 million) in financing from new and existing shareholders.

The company raised €1 million from Alsace Inter Regio Fonds d'Investissment and €500,000 from Sudinnova, both new investors. The remaining €1 million was from previous investors CIC Vizille Capital Innovation and CIC Finance.

The Strasbourg, France-based company plans to use the new funding to upgrade its research and development resources, particularly for its siRNA delivery technologies. The company also plans to hire 10 new researchers and lab technicians, which would bring its total headcount to 40.

The firm said that the new research areas it is enhancing include its siRNA delivery efforts in lung and prostate cancer models.

Filed under

Gene Silencing/Gene Editing
Business News
RNAi
siRNA
Polyplus-transfection
financing
Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.